ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Stora Enso Oyj

Stora Enso Oyj (0CX9)

12.55
0.00
(0.00%)
마감 06 12월 1:30AM

개인 투자자를 위한 전문가급 도구.

0CX9 뉴스

공식 뉴스 전용
LCJR LCJR 2 분 전
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 2 분 전
In general 
BMXI
misterfishman misterfishman 2 분 전
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 2 분 전
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 2 분 전
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 3 분 전
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 4 분 전
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 5 분 전
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 5 분 전
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 5 분 전
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 5 분 전
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 6 분 전
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 6 분 전
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 6 분 전
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 6 분 전
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 6 분 전
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 6 분 전
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 6 분 전
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 7 분 전
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 8 분 전
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ

최근 히스토리

Delayed Upgrade Clock